Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EZR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GALNT18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLCG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGHM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DIAPH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GGA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAMTS10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPAS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF259P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC43A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPTB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD276 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FCGR2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM6B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUP153 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on